2018
DOI: 10.1093/annonc/mdy281.090
|View full text |Cite
|
Sign up to set email alerts
|

ctDNA assays identify alterations in RAS, EGFR, and cMET that are unique to RAS-WT patients progressing on anti-EGFR therapy

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles